Companies that own Grifols S.A.
Jupiter Asset Management Ltd.
12,967,000
3.04%
0
1.19%
12/31/2017
OppenheimerFunds, Inc.
12,757,768
2.99%
-306,982
0.22%
05/23/2018
Capital Research & Management Co. (World Investors)
12,747,614
2.99%
-8,344,410
0.05%
11/29/2017
The Vanguard Group, Inc.
9,312,389
2.19%
85,833
0.01%
07/31/2018
DWS Investment GmbH
6,970,298
1.64%
3,994,907
0.11%
09/06/2018
Norges Bank Investment Management
6,004,868
1.41%
676,399
0.03%
12/31/2017
CAPFI DELEN Asset Management SA
5,722,780
1.34%
20,280
0.71%
06/30/2018
BlackRock Fund Advisors
5,453,545
1.28%
17,992
0.01%
09/06/2018
FIL Investment Advisors (UK) Ltd.
5,109,209
1.2%
-425,449
0.16%
05/31/2018
BlackRock Investment Management (UK) Ltd.
3,568,369
0.84%
-62,121
0.03%
06/30/2018
| Address |
Avinguda de la Generalitat, 152-158
Barcelona Catalonia 08174
Spain
|
|
Employees
|
- |
| Website |
http://www.grifols.com |
| Updated |
07/08/2019 |
| Grifols SA is a vertically integrated global producer of plasma derivatives. Its activities include sourcing raw material, manufacturing various plasma derivative products and selling and distributing final products to healthcare providers. The company operates through the following segments: Bioscience, Hospital, Diagnostic and Raw Materials. |
